FDA
-
-
-
-
-
-
-
Centogene N.V. (CNTG) and Evotec (EVO) Discover Promising New Molecule to Treat Gaucher Disease
-
-
-
-
-
-
-
Centogene N.V. (CNTG) Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
-
-
-
-
-
-
-
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
-
-
-
-
-
-
-
Centogene's (CNTG) EFRONT Study Reaches Initial Patient Enrollment Milestone
-
-
-
-
-
-
-
CENTOGENE Reports First Half 2023 Financial Results
-
-
-
-
-
-
-
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
-
-
-
-
-
-
-
Centogene (CNTG) Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

